Impact of tazobactam pharmacokinetics on the antimicrobial effect of piperacillin–tazobactam combinations
- 31 May 2004
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 23 (5) , 494-497
- https://doi.org/10.1016/j.ijantimicag.2003.10.012
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pharmacokinetic-Pharmacodynamic Modeling of the Electroencephalogram Effect of Imipenem in Healthy RatsAntimicrobial Agents and Chemotherapy, 2001
- Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusionAntimicrobial Agents and Chemotherapy, 1997
- Pharmacokinetic-Pharmacodynamic Modeling of the Antibiotic Effect of Piperacillin in VitroPharmaceutical Research, 1996
- PenicillinsDrugs, 1993
- Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanateAntimicrobial Agents and Chemotherapy, 1989
- Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilliAntimicrobial Agents and Chemotherapy, 1986
- Piperacillin kineticsClinical Pharmacology & Therapeutics, 1979